International Aids Vaccine Initiative Inc. Contracts in New York
Federal contract operations by International Aids Vaccine Initiative Inc. performed in New York (NY)
Overview
Total Contract Value: $121,853,970
Contract Count: 2
Average Contract Size: $60.9M
Sole Source Rate: 0%
Small Business Rate: 0%
Awarding Agencies
- Department of Health and Human Services — $95.6M (1 contracts)
- Department of Defense — $26.3M (1 contracts)
Spending by Sector
- Other: $121.9M (2 contracts)
Contracts
- THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN — $95.6M
- ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM — $26.3M
Frequently Asked Questions
How many contracts does International Aids Vaccine Initiative Inc. have in New York?
International Aids Vaccine Initiative Inc. has 2 contracts performed in New York worth a combined $121.9M.
What is the average contract size for International Aids Vaccine Initiative Inc. in New York?
The average contract size is $60.9M.